Nucala 100 MG/ML auto-injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FKJH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,864
Award facts
- Contract value 100% obligated
- $3,863.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,863.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Nucala 100 mg/ml auto-injector units. This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois, and supports the Department of Defense's pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products to military healthcare facilities worldwide. DMS Pharmaceutical Group's PPV-G GEN V contract, designated SPE2DR and awarded on November 13, 2025, has a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The vendor's established performance across numerous delivery orders for diverse pharmaceutical products, including specialty biologics and emergency medications, demonstrates its critical role in supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FKJH1?
SPE2DR26FKJH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FKJH1 worth?
The government has obligated $3,864 on SPE2DR26FKJH1.
Is contract SPE2DR26FKJH1 an order under another contract?
Yes. SPE2DR26FKJH1 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJH1 competed?
The extent of competition for SPE2DR26FKJH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award